Answers are grounded in this paper and cite their sources.
Ten Spinal cord injury (SCI) cases with grade 3 & 4 pressure injury (PI) were recruited.Five cases received autologous bone marrow derived mononuclear cells (BM-MNCs) therapy and five standard wound care.Significantly reduced surface area of PI in BM-MNC treated group was observed at week 6 (p=0.04) and at week 9 (p=0.001)as compared to standard wound care group.Similarly, significant reduction of depth was observed in BM-MNC group at week 9 (p<0.05)and exudate became significantly (p=0.001)lower from 3rd to 9th week.Clearance of slough and formation of red granulation tissue was significantly higher in BM-MNC group (p=0.001).The findings of this case series indicate that the use of autologous BM-MNCs could be a feasible option for the treatment of pressure injuries in SCI cases.
No takes yet. Share an insight, caveat, or question.
Rajeshwar Nath Srivastava (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: